Zobrazeno 1 - 10
of 145
pro vyhledávání: '"Vassiliki, Karantza"'
Autor:
Seock-Ah Im, Javier Cortes, David W. Cescon, Mastura Md Yusof, Hiroji Iwata, Norikazu Masuda, Toshimi Takano, Chiun-Sheng Huang, Chi-Feng Chung, Koichiro Tsugawa, Yeon Hee Park, Koji Matsumoto, Kenichi Inoue, Ava Kwong, Sherene Loi, Wei Fu, Wilbur Pan, Vassiliki Karantza, Hope S. Rugo, Peter Schmid
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-9 (2024)
Abstract In the phase 3 KEYNOTE-355 study (NCT02819518), pembrolizumab plus chemotherapy demonstrated statistically significant and clinically meaningful improvements in progression-free survival (PFS) and overall survival (OS) versus placebo plus ch
Externí odkaz:
https://doaj.org/article/779d501670554a368c8218be67b35429
Autor:
Javier Cortes, Eric P Winer, Oleg Lipatov, Seock‐Ah Im, Anthony Gonçalves, Eva Muñoz‐Couselo, Keun Seok Lee, Peter Schmid, Kenji Tamura, Laura Testa, Isabell Witzel, Shoichiro Ohtani, Stephanie Hund, Karina Kulangara, Vassiliki Karantza, Jaime A Mejia, Junshui Ma, Petar Jelinic, Lingkang Huang, Scott K Pruitt, Kenneth Emancipator
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 10, Iss 3, Pp n/a-n/a (2024)
Abstract The efficacy of pembrolizumab monotherapy versus chemotherapy increased with increasing programmed death ligand 1 (PD‐L1) expression, as quantified by combined positive score (CPS; PD‐L1 expression on both tumour cells and immune cells)
Externí odkaz:
https://doaj.org/article/42c035448af94e8fbfc51bd921ef67f3
Publikováno v:
Breast Cancer Research, Vol 21, Iss 1, Pp 1-14 (2019)
Abstract Background Metastatic triple-negative breast cancer (mTNBC), an aggressive histological subtype, has poor prognosis. Chemotherapy remains standard of care for mTNBC, although no agent has been specifically approved for this breast cancer sub
Externí odkaz:
https://doaj.org/article/9b18d12912d54052a89d6ff6e9158442
Autor:
Sung-Bae Kim, Jennifer Yearley, Rebecca Dent, Javier Cortes, Lingkang Huang, Yeon Hee Park, Theodoros Foukakis, Eva Muñoz-Couselo, Yuan Sun, Peter Schmid, Joohyuk Sohn, Seock-Ah Im, Esther Holgado, Sherko Kümmel, Petar Jelinic, Vassiliki Karantza
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/add1dbf96b064af3a4a6b15f0d9abd03
Autor:
Javier, Cortes, Hope S, Rugo, David W, Cescon, Seock-Ah, Im, Mastura M, Yusof, Carlos, Gallardo, Oleg, Lipatov, Carlos H, Barrios, Jose, Perez-Garcia, Hiroji, Iwata, Norikazu, Masuda, Marco, Torregroza Otero, Erhan, Gokmen, Sherene, Loi, Zifang, Guo, Xuan, Zhou, Vassiliki, Karantza, Wilbur, Pan, Peter, Schmid, Xiaoqiang, Xue
Publikováno v:
New England Journal of Medicine. 387:217-226
Background In an interim analysis of this phase 3 trial, the addition of pembrolizumab to chemotherapy resulted in longer progression-free survival than chemotherapy alone among patients with advanced triple-negative breast cancer whose tumors expres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e12170b9b4e60ba653c4f06a4650b81
https://doi.org/10.1056/nejmoa2202809
https://doi.org/10.1056/nejmoa2202809
Data from Autophagy Regulates Keratin 8 Homeostasis in Mammary Epithelial Cells and in Breast Tumors
Autor:
Vassiliki Karantza, Eileen White, Carola A. Neumann, Nicola Barnard, Dirk Moore, Jennifer Schulte, Fred Lozy, Irina Teplova, Olga Kravchuk, Sameera Kongara
Autophagy is activated in response to cellular stressors and mediates lysosomal degradation and recycling of cytoplasmic material and organelles as a temporary cell survival mechanism. Defective autophagy is implicated in human pathology, as disrupti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44840d5d8194075a4a02322f1337418a
https://doi.org/10.1158/1541-7786.c.6541989
https://doi.org/10.1158/1541-7786.c.6541989
Autor:
Eileen White, Robert S. DiPaola, Vassiliki Karantza-Wadsworth, Shridar Ganesan, Michael May, Cristina M. Karp, Hsin-Yi Chen, Kevin Bray
Supplementary Data from Bcl-2 Modulation to Activate Apoptosis in Prostate Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ee1b95696173bcb6703299a413291b6
https://doi.org/10.1158/1541-7786.22518924.v1
https://doi.org/10.1158/1541-7786.22518924.v1
Autor:
Vassiliki Karantza, Eileen White, Carola A. Neumann, Nicola Barnard, Dirk Moore, Jennifer Schulte, Fred Lozy, Irina Teplova, Olga Kravchuk, Sameera Kongara
Supplementary Figures S1-S2; Supplementary Materials and Methods; Supplementary Table S1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12be60bf7d719295739e224a8007c73b
https://doi.org/10.1158/1541-7786.22518552
https://doi.org/10.1158/1541-7786.22518552
Autor:
Bing Xia, Eileen White, Vassiliki Karantza, Shridar Ganesan, Nicola Barnard, Sandy Price, Guanghua Chen, Christian Bowman-Colin, Irina Teplova, Hong Cai, Yanying Huo
Supplementary Figures - PDF file 1145K, These supplementary figures (Fig. S1-S5) show the results of additional analyses of Palb2-null tumors and drived cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79ebecefa88c3ca12396290ca7915e57
https://doi.org/10.1158/2159-8290.22529670
https://doi.org/10.1158/2159-8290.22529670
Autor:
Bing Xia, Eileen White, Vassiliki Karantza, Shridar Ganesan, Nicola Barnard, Sandy Price, Guanghua Chen, Christian Bowman-Colin, Irina Teplova, Hong Cai, Yanying Huo
Supporting information - PDF file 51K, Supplementary Materials and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e565422615485f8912a32728445fe88
https://doi.org/10.1158/2159-8290.22529667
https://doi.org/10.1158/2159-8290.22529667